Page last updated: 2024-08-26

dihydroisotanshinone i and Cancer of Cervix

dihydroisotanshinone i has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y; Wang, C; Xu, W; Ye, Y; Zhong, W1

Other Studies

1 other study(ies) available for dihydroisotanshinone i and Cancer of Cervix

ArticleYear
Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.
    Molecular and cellular biochemistry, 2012, Volume: 363, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Chemoradiotherapy; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Female; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gamma Rays; HeLa Cells; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Papillomaviridae; Phenanthrenes; Time Factors; Tumor Burden; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2012